脑出血后血压控制目标与心脑血管事件风险
该研究分析1828例自发性脑出血幸存者,随访中位46.2个月,发现收缩压<120 mmHg者较120-129 mmHg者复发性脑出血和主要不良心脑血管事件风险降低,但年龄>75岁或改良Rankin量表评分4-5分者收缩压<120 mmHg与全因死亡风险增加相关,舒张压<70与70-79 mmHg无差异。
要点
- 收缩压<120 mmHg与复发性脑出血风险降低相关(AHR 0.74,95%CI 0.59-0.94)。
- 收缩压<120 mmHg与主要不良心脑血管事件风险降低相关(AHR 0.69,95%CI 0.53-0.92)。
- 年龄>75岁或改良Rankin量表评分4-5分者收缩压<120 mmHg与全因死亡风险增加相关。
核心结论
- 在特定脑出血幸存者中,以收缩压<120 mmHg为靶目标可能降低主要不良心脑血管事件风险而不增加死亡风险。
- 作者认为该发现需在专门设计的随机对照试验中进一步研究。
研究设计与样本
- 研究分析了来自2项队列研究的1828例自发性脑出血幸存者。
- 脑出血后3个月和6个月记录随访血压,此后每6个月记录一次。
- 结局包括主要不良心脑血管事件(复发性脑出血、新发缺血性卒中、心肌梗死)、血管性死亡和全因死亡。
主要发现
- 中位随访46.2个月期间,观察到166例复发性脑出血、68例缺血性卒中、69例心肌梗死和429例死亡。
- 与收缩压120-129 mmHg的脑出血幸存者相比,收缩压<120 mmHg者复发性脑出血风险降低(AHR 0.74,95%CI 0.59-0.94),主要不良心脑血管事件风险降低(AHR 0.69,95%CI 0.53-0.92)。
- 收缩压<120 mmHg者全因死亡(AHR 0.76,95%CI 0.57-1.03)和血管性死亡(AHR 0.68,95%CI 0.45-1.01)与收缩压120-129 mmHg者相比无显著差异。
- 在年龄>75岁或改良Rankin量表评分4-5分的参与者中,收缩压<120 mmHg与全因死亡风险增加相关(AHR分别为1.38,95%CI 1.02-1.85和1.36,95%CI 1.03-1.78),但与血管性死亡无关。
- 舒张压<70 mmHg与70-79 mmHg的脑出血幸存者之间结局发生率无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
- 作者指出该发现需在专门设计的随机对照试验中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracerebral hemorrhage (ICH) survivors are at high risk for recurrent stroke and cardiovascular events. Blood pressure (BP) control represents the most potent intervention to lower these risks, but optimal treatment targets in this patient population remain unknown. We sought to determine whether survivors of ICH achieving more intensive BP control than current guideline recommendations (systolic BP <130 mmHg and diastolic BP <80 mmHg) were at lower risk of major adverse cardiovascular and cerebrovascular events and mortality. METHODS: We analyzed data for 1828 survivors of spontaneous ICH from 2 cohort studies. Follow-up BP measurements were recorded 3 and 6 months after ICH, and every 6 months thereafter. Outcomes of interest were major adverse cardiovascular and cerebrovascular events (recurrent ICH, incident ischemic stroke, myocardial infarction), vascular mortality (defined as mortality attributed to recurrent ICH, ischemic stroke, or myocardial infarction), and all-cause mortality. RESULTS: During a median follow-up of 46.2 months, we observed 166 recurrent ICH, 68 ischemic strokes, 69 myocardial infarction, and 429 deaths. Compared with survivors of ICH with systolic BP 120 to 129 mmHg, participants who achieved systolic BP <120 mmHg displayed reduced risk of recurrent ICH (adjusted hazard ratio [AHR], 0.74 [95% CI, 0.59-0.94]) and major adverse cardiovascular and cerebrovascular events (AHR, 0.69 [95% CI, 0.53-0.92]). All-cause mortality (AHR, 0.76 [95% CI, 0.57-1.03]) and vascular mortality (AHR, 0.68 [95% CI, 0.45-1.01]) did not differ significantly. Among participants aged >75 years or with modified Rankin Scale score 4 to 5, systolic BP <120 mmHg was associated with increased all-cause mortality (AHR, 1.38 [95% CI, 1.02-1.85] and AHR, 1.36 [95% CI, 1.03-1.78], respectively), but not vascular mortality. We found no differences in outcome rates between survivors of ICH with diastolic BP <70 versus 70 to 79 mmHg. CONCLUSIONS: Targeting systolic BP <120 mmHg in select groups of survivors of ICH could result in decreased major adverse cardiovascular and cerebrovascular events risk without increasing mortality. Our findings warrant investigation in dedicated randomized controlled trials.
引用
- Teo KC, Keins S, Abramson JR, et al. Blood Pressure Control Targets and Risk of Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage. Stroke. 2022. PMID: 36321455. doi:10.1161/STROKEAHA.122.039709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。